KPCB XIV Associates, LLC

CIK 1546196 · last filed 2019-11-04

KPCB XIV Associates, LLC is a corporate insider who has filed 3 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for OYST, was dated Nov 4, 2019. Current disclosed insider exposure totals $2.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$2.76M

Companies

3

Total Filings

3

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Oyster Point Pharma, Inc. (OYST) Delisted	10%+ Owner	367,987	$11.17	$4.11M	$0	1	2019-11-04
BYND	10%+ Owner	4,919,321	$0.56	$2.76M	$0	1	2019-10-31
Foundation Medicine, Inc. (FMI) Delisted	10%+ Owner	42,495	—	—	$0	1	2015-04-09

Recent Filings

3 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2019-11-04	Oyster Point Pharma, Inc. (OYST) Delisted	Conv (C)	+136,587	$0	EDGAR
2019-10-31	BYND	Other (J)	−6,324,840	$0	EDGAR
2015-04-09	Foundation Medicine, Inc. (FMI) Delisted	U	−6,834,036	-$341.70M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.